Belle Dumé[email protected]Molecular ImagingRetinal imaging goes high resolutionAge-related macular degeneration affects 26% of Europeans over 60, but its early signs are hard to detect. Swiss researchers have developed a technique that makes it possible to observe the retinal cells involved in the disease in vivo.May 24, 2020Molecular ImagingMagnetized molecules monitor breast cancersA new technique that uses hyperpolarized carbon-13 MRI to monitor the metabolism of different types of breast cancer can identify how rapidly a tumor is growing, U.K. researchers report. The approach could help doctors prescribe the best course of treatment and follow how patients respond.March 5, 2020Clinical NewsHuman protein-based nanoprobes for MRIAn international team of researchers is reporting on the first-ever human protein-based tumor-targeting MRI contrast agent. The biohybrid composite, which can also be easily cleared by the body, could be used to detect tumors in their early stages, thanks to its enhanced MRI contrast and shorter proton relaxation time.July 6, 2017Clinical NewsSmall fluorescent dye eases NIR-II imagingResearchers are reporting on the first small-molecule fluorescent dye for "near-infrared-II" (NIR-II) imaging. The dye, which is rapidly excreted by the body, could be used to image tumors in vivo and for image-guided surgery and therapy (Nature Materials, 23 November 2015).December 10, 2015Page 1 of 1Top StoriesWomens ImagingEUSOBI puts focus on assisted reproductive technologiesThere's an urgent need to cast light on the link between assisted reproductive technologies and breast cancer risk, researchers noted at the European Society of Breast Imaging (EUSOBI) annual congress.Artificial IntelligenceWill AI lead to merger of radiology and pathology?CTU.K. newspaper exposes scandal of European radiologistWomens ImagingMissed previous mammography screening linked to worse disease outcomesSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar